X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - New Drug Approvals - 21/Jun 23:06

FDA Converts Tuberculosis Treatment Sirturo to Traditional Approval

On June 21, 2024, the FDA converted Sirturo (bedaquiline) from accelerated approval to traditional approval following a determination that a confirmatory trial verified clinical benefit. Sirturo is indicated for pulmonary tuberculosis (TB) due to...

Articles similaires

Sorry! Image not available at this time

Chronic Pulmonary Infections Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Teva Pharma, Merck, F. Hoffmann-La Roche, Novartis, GSK

mountaintoday.in - 01/Oct 11:48

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Chronic Pulmonary Infections pipeline constitutes 10+ key companies...

Sorry! Image not available at this time

FDA approves selpercatinib for RET fusion-positive medullary thyroid cancer

oncologynews.com.au - 02/Oct 11:01

On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib for adult and pediatric patients 2 years of age...

Sorry! Image not available at this time

InnoCare Pharma gets Chinese nod to begin clinical trial of BCL2 inhibitor ICP─248 for acute myeloid leukaemia

pharmabiz.com - 20/Sep 16:36

InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced the approval of the...

Sorry! Image not available at this time

The powerful treatment regimen redefining tuberculosis care in Somalia

hiiraan.com - 30/Sep 04:44

A new treatment regimen called BPaLM is making it easier for Somali MDR-TB patients to complete their full course of medications.

Sorry! Image not available at this time

Ideaya reports positive interim phase 2 data for darovasertib and successful US FDA Type C meeting on registrational trial design for regulatory approval in neoadjuvant UM

pharmabiz.com - 24/Sep 21:03

Ideaya Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced...

Sorry! Image not available at this time

CD (Suzhou) Biopharma gets US FDA clearance to begin phase I trial of CD─001

pharmabiz.com - 23/Sep 14:54

CD(Suzhou) Biopharma, a rapidly advancing clinical─stage biotech company, has received clearance from the US Food and Drug Administration (FDA) for...

Sorry! Image not available at this time

FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease

drugs.com - 01/Oct 22:48

TUESDAY, Oct. 1, 2024 -- The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with...

Sorry! Image not available at this time

FDA Grants Traditional Approval to Retevmo (selpercatinib) for Medullary Thyroid Cancer with a RET Mutation

drugs.com - 27/Sep 03:09

On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and...

Sorry! Image not available at this time

FDA Grants Traditional Approval to Retevmo (selpercatinib) for Medullary Thyroid Cancer with a RET Mutation

drugs.com - 27/Sep 03:09

On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and...

Sorry! Image not available at this time

Epidermolysis Bullosa Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | RegeneRx Biopharma, BridgeBio Pharma, Berg Pharma, Holostem

mountaintoday.in - 26/Sep 11:44

Epidermolysis Bullosa pipeline constitutes 20+ key companies continuously working towards developing 21+ Epidermolysis Bullosa treatment therapies,...

Les derniers communiqués